JACARDI: Joint Action on CARdiovascular diseases and DIabetes

JACARDI aims to support EU countries to reduce the burden of cardiovascular diseases (CVDs) and diabetes mellitus (DM) and related risk factors, both at individual and societal level, while assuring health systems sustainability and equity.

Grant agreement ID: 101126953 

Principal investigator: Rosanna Tarricone 

Team UB/Cergas: Carla Rognoni, Aleksandra Torbica, Amelia Compagni, Francesco Longo, Giovanni Fattore (CeRGAS) 

Partners: (77) ISTITUTO SUPERIORE DI SANITA’ (ISS, Coordinator), AZIENDA LIGURE SANITARIA DELLA REGIONE LIGURIA, AZIENDA OSPEDALIERA UNIVERSITARIA POLICLINICO, PAOLO GIACCONE DI PALERMO, AZIENDA SANITARIA LOCALE TO3, AZIENDA SANITARIA PROVINCIALE REGGIO CALABRIA, AZIENDA ULSS 4 VENETO ORIENTALE, UNIVERSITA COMMERCIALE LUIGI BOCCONI, FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA, FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO, GEMELLI IRCCS, ISTITUTI CLINICI SCIENTIFICI MAUGERI SOCIETA' PER AZIONI SOCIETA' BENEFIT, ISTITUTO NAZIONALE DI RIPOSO E CURA PER ANZIANI INRCA, ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO BURLO GAROFOLO, REGIONE MARCHE, MINISTERO DELLA SALUTE, PROVINCIA AUTONOMA DI TRENTO, REGIONE LOMBARDIA, UNIVERSITA DEGLI STUDI DI FIRENZE, UNIVERSITA DEGLI STUDI DI TORINO, SCIENSANO, Diabetes Liga vzw, KATHOLIEKE UNIVERSITEIT LEUVEN, UNIVERSITEIT ANTWERPEN, Ministry of Health of the Republic of Cyprus, HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO, STATNI ZDRAVOTNI USTAV, TERVEYDEN JA HYVINVOINNIN LAITOS, Finnish Diabetes Association, TYOTERVEYSLAITOS, SUOMEN SYDANLIITO RY, ITA-SUOMEN YLIOPISTO, AGENCE NATIONALE DE SANTE PUBLIQUE, CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES, Centre Hospitalier de Paimpol, CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS, HOSPICES CIVILS DE LYON, MINISTRY OF HEALTH, INSTITOUTON YGEIAS TOU PAIDIOU, SEMMELWEIS EGYETEM, ORSZAGOS KORHAZI FOIGAZGATOSAG, GOTTSEGEN GYORGY ORSZAGOS KARDIOLOGIAI, INTEZET, LANDLAEKNIS EMBAETTID, Heilsugaesla Hofudborgarsvaedisins, HEALTH SERVICE EXECUTIVE HSE, Croi West of Ireland Heart Foundation, SLIMIBU PROFILAKSES UN KONTROLES CENTRS, LATVIJAS BIOMEDICINAS PETIJUMU UN STUDIJU CENTRS, HIGIENOS INSTITUTAS, Ministry for Health - Government of Malta, HELSEDIREKTORATET, UNIWERSYTET MEDYCZNY IM KAROLA, MARCINKOWSKIEGO W POZNANIU, SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH, MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA, ASSOCIACAO PROTECTORA DOS DIABETICOS DE PORTUGAL, UNIVERSIDADE NOVA DE LISBOA, INSTITUTUL NATIONAL DE SANATATE PUBLICA, CASA NATIONALA DE ASIGURARI DE SANATATE, Emergency Institute for Cardiovascular Disease and Transplant Targu Mures, Institutul National de Diabet Nutritie si Boli Metabolice "N. C. Paulescu", NACIONALNI INSTITUT ZA JAVNO ZDRAVJE, UNIVERZA V LJUBLJANI, VICEPRESIDENCIA SEGUNDA Y CONSEJERIA DE SANIDAD Y SERVICIOS SOCIALES - JUNTA DE EXTREMADURA, CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.), FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, FUNDACION PARA LA FORMACION E INVESTIGACION DE LOS PROFESIONALES DE LASALUD DE EXTREMADURA FUNDESALUD, FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA, INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD, FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA, FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA, FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA, FUNDACION DE LA COMUNITAT VALENCIANA PARA LA GESTION DEL INSTITUTO DEINVESTIGACION SANITARIA Y BIOMEDICADE ALICANTE, ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SERVICIOS DE SALUD-KRONIKGUNE, STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE, Direzione Generale per la Salute e le Politiche alla Persona Regione Basilicata, AZIENDA SANITARIA LOCALE ROMA 1, REGIONE CAMPANIA, REGIONE UMBRIA. 

Sponsor: European Health and Digital Executive Agency (HaDEA) (Call EU4H-2022-JA-IBA)  

Duration: November 2023-November 2027 

Abstract:

The Joint Action on CARdiovascular diseases and DIabetes (JACARDI) aims to reduce the burden of cardiovascular disease (CVD) and diabetes (DM) in EU countries, both at individual and societal level. JACARDI is designed to integrate validated best practices and/or (cost-)effective interventions across countries and regions through transnational pilot initiatives, complementing and reinforcing existing policies and programs. The initiative covers the entire "patient journey”, from improving health literacy and awareness of CVD/DM, travelling through screening and primary prevention among high-risk populations, reaching people living with CVD/DM and their care providers, improving service pathways, self-management, and labour participation. JACARDI also addresses transversal and intersectional aspects, e.g., promoting equity in health, social, cultural, and ethnic diversity and the improvement of data availability. The activities are distributed into 11 Work Packages (WPs): 5 transversal WPs, with one innovative WP on the development of a common methodological framework and integrative approach, and 6 technical WPs. The wide coverage of JACARDI is secured by the involvement of 21 EU countries and 77 partners. The widespread implementation of 142 pilots will ensure broad coverage and geographic extension, while the adoption of a common implementation and assessment methodology will minimise the risks of failure and facilitate the analysis of success and context factors. The resulting roadmap will serve as proof-of concept case studies with the potential to extend and scale-up experiences at the national/regional level. JACARDI will enhance cross-national collaboration, maximising the exploitation of lessons learned through a clear strategy, engaging groups of interest, promoting integration and sustainability of approaches to achieve high-level impact, including the implementation of effective interaction, cooperation and co-creation between science and policy.